Grants and Support

Anthony J. Aldave, MD 

Ocunexus Therapeutics

Role:               Site Principal Investigator

Duration:         10/1/21-9/30/26

Description:     A Phase 2, randomized, prospective, double-masked, vehicle-controlled study to assess the efficacy and safety of Nexagon® applied topically in subjects with corneal persistent epithelial defects (PED) resulting from severe ocular chemical and/or thermal injuries.

Oyster Point Pharma, Inc.

Role:               Site Principal Investigator

Duration:         8/11/21-8/10/26

Description:     A Phase 2, Multicenter, Randomized, Controlled, Double-Masked, Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray in Subjects with Neurotrophic Keratopathy (the Olympia Study

NIH/National Eye Institute

Role:               Site Principal Investigator

Duration:         05/01/21-04/30/26

Description:     Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes on Corneal Transplant Success and Cell Loss

Eye Bank Association of America

Role:               Principal Investigator

Duration:         07/01/21-06/30/22

Description:     EBAA Pilot Research Grant: Does COVID-19 vaccination increase the risk of corneal transplant rejection?

UCLA Faculty Research Grant

Role:               Principal Investigator

Duration:         07/01/21-06/30/22

Description:     Determining the impact of SLC4A11 deficiency on oxidative stress and assessing the therapeutic effect of SkQ1 treatment in SLC4A11-deficient cell-based models of corneal endothelial dystrophies

UCLA Global Health Seed Grant

Role:               Principal Investigator

Duration:         06/01/21-05/31/22

Description:     Prospective clinical trial evaluating the usage of sterile preserved cornea tissue in treating infectious corneal perforation in Vietnam

Doug Chung, PhD

Knights Templar Eye Foundation Career Starter Grant

Role:               Principal Investigator

Duration:         07/01/21-06/30/22

Description:     Elucidating the role of SLC4A11 in Congenital Hereditary Endothelial Dystrophy

Wenlin Zhang, MD, PhD

ARVO Foundation/EBAA EyeFind Research Grant

Role:               Principal Investigator

Duration:         07/01/21-06/30/22

Description:     Quantitative super-resolution localization of SLC4A11 variants in human corneal endothelium in its native environment